Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - UroMed Corporation (OTC BB:URMD.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Insider | Financials
Location
1400 Providence Highway
Norwood, MA 02194
Phone: (781) 762-2080
Fax: (781) 433-0032
Email: webmaster@uromed.com
Employees (last reported count): 54
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 62%
·Institutional: 2% (6% of float)
(6 institutions)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
UroMed Corporation specializes in interventional urological products, with primary emphasis on the treatment of prostate cancer. The Company seeks to market a portfolio of products, including its two main proprietary products for the treatment of prostate cancer, the CaverMap Surgical Aid, available to aid physicians in preserving vital nerves during prostate cancer surgery, and the Symmetra Iodine-125 (Symmetra I-125) radioactive seeds, used in a brachytherapy procedure to treat localized prostate cancer. The Company's product portfolio also includes brachytherapy introducer needles. The Company also continues to dedicate resources to the development and/or acquisition of product lines that fit into its strategic platform.
More from Market Guide: Expanded Business Description

Financial Summary
UroMed Corporation is a provider of urological products, with a primary emphasis on prostate cancer. The Company also has developed and acquired technology in urinary incontinence products and in breast cancer detection. For the six months ended 6/30/01, revenues rose 12% to $2.5 million. Net loss before extraordinary item rose 71% to $3.7 million. Results reflect higher software systems and support revenues, offset by increased personnel and amortization expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

John Simon, 38
Chairman
$225K$9.3K
Daniel Muscatello, 45
Pres, Director, CEO
292K11.4K
Paul Pagano, 49
VP of Domestic Sales
122K--  
Domenic Micale, 36
VP of Fin. and Admin., Treasurer
118K46.6K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:URMD.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Nov-2000
$0.50 
Recent Price$1.25 
52-Week High
on 3-Jan-2001
$4.75 
Beta-0.44 
Daily Volume (3-month avg)17.0K
Daily Volume (10-day avg)20.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-34.4%
52-Week Change
relative to S&P500
-12.0%
Share-Related Items
Market Capitalization$9.15M
Shares Outstanding7.32M
Float2.80M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 19-May-1998
Per-Share Data
Book Value (mrq)-$0.13 
Earnings (ttm)-$1.37 
Earnings (mrq)-$0.32 
Sales (ttm)$0.80 
Cash (mrq)$0.79 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)1.57 
Income Statements
Sales (ttm)$4.58M
EBITDA (ttm)-$7.02M
Income available to common (ttm)-$7.83M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-46.03%
Return on Equity (ttm)-3708.53%
Financial Strength
Current Ratio (mrq)2.28 
Debt/EquityN/A 
Total Cash (mrq)$5.78M
Short Interest
As of 8-Dec-2000
Shares Short0 
Shares Short
(Prior Month)
23.0K
Daily Volume53.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.